title: Longitudinal changes in patient vs. physician-based outcome measures did not significantly correlate in asthma.
abstract: OBJECTIVE
  Although improving health status is one important aim in managing asthmatic patients, few studies have evaluated their health status longitudinally. Therefore, we examined longitudinal changes in health status of asthma patients, and compared them with changes in physiological measures.
  
  
  METHODS
  Eighty-seven outpatients with stable asthma after 6 months of treatment were recruited. Health status using the Asthma Quality of Life Questionnaire (AQLQ) and the St. George's Respiratory Questionnaire (SGRQ), pulmonary function, peak expiratory flow (PEF) values, and airway hyperresponsiveness (AHR) were evaluated at entry and every year over a 5-year period.
  
  
  RESULTS
  Using mixed effects models to estimate the slopes, the overall AQLQ score declined statistically at a mean rate of 0.06 units/year (P=.0091). However, this decline did not reach a clinically significant level at 5 years. The total SGRQ score did not change significantly (P=.54). Although the forced expiratory volume in 1 sec declined at a mean rate of 53 mL/year, the PEF variability and AHR improved significantly.
  
  
  CONCLUSIONS
  Health status was clinically stable over the 5-year study period in patients with asthma, which contrasted with the changes in the physiological outcome measures. As a patient centered outcome measure, health status should be followed separately.
authors.affiliation: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 53 Kawahara, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. ogat@df7.so-net.ne.jp
authors.forename: Toru
authors.initials: T
authors.lastname: Oga
authors.forename: Koichi
authors.initials: K
authors.lastname: Nishimura
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Tsukino
authors.forename: Susumu
authors.initials: S
authors.lastname: Sato
authors.forename: Takashi
authors.initials: T
authors.lastname: Hajiro
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Koyama
authors.forename: Michiaki
authors.initials: M
authors.lastname: Mishima
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001985:Bronchial Provocation Tests; D005260:Female; D005541:Forced Expiratory Volume; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D008168:Lung / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D011379:Prognosis; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones